Why Too Many AI-Native Startups Destroy Value Before They Even Reach €1M ARR

Picture a promising AI-native startup. They have a product that actually works. Solid seed investors. Two SDRs consistently booking 20+ meetings a month. Target deal sizes ranging from €30K to €120K. The founders are deeply involved, leading the GTM motion personally.

They are raising a new round of a few million, getting ready to scale. Everything looks exactly how a high-growth startup should look. Until you scratch the surface.

They haven’t crossed the €1M ARR mark yet. Still missing a few hundred thousands. The founders have already diluted their equity down to 50% before Series A.

Then, you look at the conversion rate from first meeting to closed-won: 3%.

The number itself didn’t worry me. What worried me was everything it implied.

The Pattern of Pipelines Not Converting 

This is a systematic cycle I am seeing right now with many AI-native startups.

They raise an early round. So they build a product that solves a real problem. They build a pipeline of meetings. The meetings happen. Then opportunities open.

They do pilots. Even paid pilots. Then the pipeline does not convert. Deals drag on. And the founders can’t figure out why.

A 3% conversion rate, when founders are doing the selling is a symptom of something that usually early stage founders struggle to realise.

It means nobody has stopped to ask the most critical Go-To-Market question:

“What is the one conversation we want to win every single time?”

And underneath that question sits an even more uncomfortable one:

“What are we genuinely willing not to sell?”

Because focus is first of all deciding what you are willing to leave behind.

When you don’t have an answer to that, you start chasing ghosts.

The False Problem: Make vs. Buy

When pipeline converts poorly, founders today often gravitate towards the “Make vs. Buy” objection.

“Our prospects say they can just build this internally using OpenAI APIs.”

This is true. Prospects do say that. But it is the symptom, not the root cause.

“Make vs. Buy isn’t usually a sales objection. It’s often a qualification mistake.”

If you are talking to tech companies with strong engineering teams, “make” is always going to be an option. Not because your product isn’t valuable, but because you are knocking on the wrong door, or at the wrong time.

The true GTM skill isn’t convincing stubborn engineers and their leaderships not to build. It is knowing where not to push, and where to nurture for 12 to 24 months instead.

Because the pendulum often swings back. Engineering teams that build internal AI tools today tend to underestimate the ongoing cost of maintaining what they built. Two years later, the technical debt is real, the team that built it has moved on, and the original problem is still there. When that moment arrives, you want to already be inside the conversation, not starting it from scratch.

The True Problem: No Killer Use Case

These startups usually scramble to get their first 10 or 20 customers. To do it, they sell five different use cases to five different types of buyers. In different verticals and sectors.

The founders look at these logos and think they have found Product-Market Fit. In reality, they have only found product adaptability.

Early customers prove your product can adapt. They don’t prove you have a scalable GTM.

That is exactly what makes this stage so dangerous. Adaptability is often mistaken for focus.

Today, rather than an AI platform, what you sell in reality is the result of a specific, measurable, defensible use case.

The killer use case isn’t necessarily the broadest one. It is the one where you have the strongest story, the clearest ROI, and the most defined buyer.

If your product can do three amazing use cases, the question isn’t how to sell all three. The question is: which one do you want to dominate first?

Without a killer use case, the pipeline stalls because every deal is a completely different conversation. The founders cannot transfer the sales motion to anyone else because there is nothing to transfer. There is only personal talent and improvisation.

The Structural Error

Because the pipeline looks full, the founders go out to raise another round to accelerate.

So I asked: What’s the plan after raising?

“We want to hire an experienced Head of Sales who will bring his or her team”

Why?

“Pipeline isn’t converting. We need someone to bring their network, build a team, and scale revenue.”

If founders who know the product perfectly are closing at 3%, what exactly is the VP of Sales supposed to scale?

Scaling a team before having a repeatable playbook doesn’t accelerate growth. It multiplies confusion.

You cannot hire a VP of Sales to invent your GTM from scratch. You hire them to execute and scale a playbook that already works. In AI, a “rolodex of contacts” will not save a company that lacks a killer use case.

Hiring a sales team right now means burning cash on people who cannot succeed, because the system they need to operate within doesn’t exist yet.

The paradox is that the moment you have the most money in the bank is often the most dangerous moment to hire commercial talent.

And this is where the problem stops being just a GTM problem and becomes a value creation problem.

If you are still below €1M ARR, the founders already own only 50% of the company, and the next few million are being raised to scale a motion that converts at 3%, you are not simply taking execution risk.

You are using increasingly expensive equity to finance GTM uncertainty.

What To Do Instead

Look at your 20 customers.

Find the killer use case. Test the conversion on that specific use case yourself, as a founder. Build the playbook around that single, highly-converting motion.

Only then, you scale.

Value is not created by raising a bigger round or hiring a bigger team. Value is created by knowing exactly what you are selling, exactly who you are selling it to, and exactly why they buy.

The most dangerous moment in a startup (after running out of money) is when you’ve just raised enough to scale a GTM system you still don’t fully understand.

Because capital doesn’t fix GTM confusion. It gives you the money to scale it.

And when you’re already heavily diluted before €1M ARR, scaling confusion doesn’t just burn cash.

It destroys value.